TW200511986A - Antifungal composition - Google Patents

Antifungal composition

Info

Publication number
TW200511986A
TW200511986A TW093110688A TW93110688A TW200511986A TW 200511986 A TW200511986 A TW 200511986A TW 093110688 A TW093110688 A TW 093110688A TW 93110688 A TW93110688 A TW 93110688A TW 200511986 A TW200511986 A TW 200511986A
Authority
TW
Taiwan
Prior art keywords
benzylamine
composition
fungi agent
series anti
series
Prior art date
Application number
TW093110688A
Other languages
Chinese (zh)
Inventor
Shigeki Sawamura
Original Assignee
Kobayashi Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Seiyaku Kabushiki Kaisha filed Critical Kobayashi Seiyaku Kabushiki Kaisha
Publication of TW200511986A publication Critical patent/TW200511986A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A product has high therapeutic effect adaptating with the symptom of moisture type epi-existence fungus disease is provide. An antifungi composition which is consisted by mixing lipid acid ester﹑powder component﹑alcoholic solvent and anti-itching component in benzylamine series anti-fungi agent. Preferred benzylamine series anti-fungi agent is at least one selected from the group consisting of Butenafine and its salt. The combination amount of benzylamine series anti-fungi agent within composition is 0.05~5 wt%.
TW093110688A 2003-09-30 2004-04-16 Antifungal composition TW200511986A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003341723A JP2005104917A (en) 2003-09-30 2003-09-30 Antifungal composition

Publications (1)

Publication Number Publication Date
TW200511986A true TW200511986A (en) 2005-04-01

Family

ID=34419218

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093110688A TW200511986A (en) 2003-09-30 2004-04-16 Antifungal composition

Country Status (3)

Country Link
JP (1) JP2005104917A (en)
TW (1) TW200511986A (en)
WO (1) WO2005032531A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI793184B (en) * 2017-09-29 2023-02-21 日商信越化學工業股份有限公司 Deodorizing, antibacterial, and antifungal agent, method for producing same, and member having deodorizing, antibacterial, and antifungal agent on its surface

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3800232B2 (en) * 2004-09-30 2006-07-26 小林製薬株式会社 Antifungal composition for external use
JP5872131B2 (en) * 2006-11-29 2016-03-01 ロート製薬株式会社 Antifungal pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106332A (en) * 1997-08-07 1999-04-20 Taisho Pharmaceut Co Ltd Powdery aerosol preparation
JP4863538B2 (en) * 1999-12-22 2012-01-25 武田薬品工業株式会社 Antifungal liquid composition for external use
JP2001233764A (en) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Antipruritic agent comprising n-substituted-o-toluidine derivative
JP2002284702A (en) * 2001-01-19 2002-10-03 Teika Seiyaku Kk Antifungal pharmaceutical preparation for external use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI793184B (en) * 2017-09-29 2023-02-21 日商信越化學工業股份有限公司 Deodorizing, antibacterial, and antifungal agent, method for producing same, and member having deodorizing, antibacterial, and antifungal agent on its surface

Also Published As

Publication number Publication date
WO2005032531A1 (en) 2005-04-14
JP2005104917A (en) 2005-04-21

Similar Documents

Publication Publication Date Title
TW200738280A (en) Novel pharmaceutical compositions comprising levetiracetam and process for their preparation
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL195033A0 (en) Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
TW200514772A (en) Novel tetrahydropyridine derivatives
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200621773A (en) Bicyclononene derivatives
WO2001082938A3 (en) Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2005030209A8 (en) Pyridine derivatives and use thereof as urotensin ii antagonists
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
WO2005054244A3 (en) Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
MXPA05011496A (en) Azabicyclononene derivatives.
WO2009055084A3 (en) Vitamin c compositions
NZ543172A (en) Uptake of macromolecules
WO2008023003A8 (en) Drug combinations for treating airway diseases
TW200511986A (en) Antifungal composition
TW200628167A (en) Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2005006860A3 (en) Azole derivatives and methods for making the same
ID28705A (en) COMPOSITION CONSIST OF ASCORBATE ACID AND PEKTIN